CXCL12 and prostate carcinoma: Studies to understand the cause of Treg cells migration into bone compartment in prostate cancer patients revealed that chemokine CXCL12, known for its role in stimulating tumor growth, was higher in prostate cancer patients with bone metastasis (Figure 2).